Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
29.44
+0.20 (0.68%)
At close: Apr 14, 2026, 4:00 PM EDT
29.44
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:27 PM EDT

Assembly Biosciences Revenue

In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth. Assembly Biosciences had revenue of $42.47M in the quarter ending December 31, 2025, with 477.26% growth.

Revenue (ttm)
$72.30M
Revenue Growth
+153.52%
P/S Ratio
6.46
Revenue / Employee
$990,452
Employees
73
Market Cap
467.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
REGENXBIO170.44M
Sutro Biopharma102.48M
XOMA Royalty52.15M
Verastem30.91M
Zentalis Pharmaceuticals26.87M
Absci2.80M
YD Bio510.36K
vTv Therapeutics17.00K
Revenue Rankings